Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05598983

Non-contact Proactive Remote Monitoring of COPD Exacerbations

The goal of this observational study is to determine if a COPD exacerbation can be detected early in its onset. The main questions it aims to answer are:

* Can an exacerbation be detected before the person recognizes they are unwell? * What are the biological signals which provide the best indication of decompensation? * How does this indication of decompensation compare to a daily CAT?

Participants will be asked to place a device, DistaSense, on top of their mattress and then sleep as normal. In addition, they will be asked to complete a daily CAT.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

COPD Exacerbation

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Royal Free Hospital

London, United Kingdom

Location status: Recruiting

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Confirmed diagnosis of COPD
  • 1 or more exacerbation in the last year
  • Aged over 18 years
  • Willing to use monitoring devices and complete study questionnaires
  • Adequate English
  • Signed consent form

Exclusion criteria

  • Pregnancy
  • BMI greater than 45 kg/m2
  • Nil other, provided inclusion criteria are met.

Treatment and study plan

Primary outcomes

  1. Track the adherence of DistaSense

    Time frame: 12 months

    To evaluate the adherence of patients using DistaSense, a non-contact vital sign monitor that measures heart rate and respiration rate, we will be tracking the patient dropout rate over the course of the 12 month study period.

  2. Understand the patient acceptance of DistaSense

    Time frame: 12 months

    To evaluate the patient acceptance of using DistaSense, a non-contact vital sign monitor that measures heart rate and respiration rate, we will be requesting patients complete a Technology Assessment Model Fast Form (TAM-FF) every 3 months during the 12 month trial period.

  3. Ability to detect COPD exacerbations

    Time frame: 3 - 12 months

    To evaluate the ability of a non-contact remote monitoring techniques to detect exacerbations of COPD.

Study contacts

Contact information is provided by the study sponsor or research team.

Eric Howie

CONTACT

[email protected]

4084213151

Peter Rule

CONTACT

[email protected]

6502795261

Sponsors and collaborators

Lead sponsor

Life Detection Technologies

Industry

Collaborators

  • Royal Free Hospital NHS Foundation Trust

Registry information

Official study title

Non-contact Proactive Remote Monitoring to Facilitate Early Detection of Exacerbations in Chronic Obstructive Pulmonary Disease (COPD)

Acronym: DetectEx

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Oct 31, 2022
Registry last updated
Mar 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.